Journal article
Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize Study
- Abstract:
- Extrafine, single-inhaler BDP/FF/G therapy was effective and safe in a routine clinical practice setting in a multi-national cohort of patients with moderate to severe asthma.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 7.9MB, Terms of use)
-
- Publisher copy:
- 10.2147/jaa.s582286
Authors
- Publisher:
- Taylor and Francis Group
- Journal:
- Journal of Asthma and Allergy More from this journal
- Volume:
- Volume 19
- Pages:
- 1-21
- Publication date:
- 2026-02-01
- DOI:
- EISSN:
-
1178-6965
- ISSN:
-
1178-6965
- Language:
-
English
- Keywords:
- Pubs id:
-
2383895
- Local pid:
-
pubs:2383895
- Source identifiers:
-
W7130528829
- Deposit date:
-
2026-03-04
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
If you are the owner of this record, you can report an update to it here: Report update to this record